BioStock: Almi Invest comments on its exit in Lipum

Lipum recently announced that Flerie Invest has acquired all of Almi Invest’s shares and warrants in Lipum. Almi Invest was Lipum’s first investor when they made a seed investment of 2.5 MSEK in 2016. Since then, Lipum has made significant progress in its preclinical drug development and has been listed on Nasdaq First North Growth Market. To find out more about Lipum’s journey, BioStock contacted Mattias Eriksson, Investment Manager at Almi Invest.

Read the full article at biostock.se:

https://www.biostock.se/en/2021/12/almi-invest-comments-on-its-exit-in-lipum/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se